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ABSTRACT
During transcription by RNA polymerase (RNAP) II,
the incoming ribonucleoside triphosphate (NTP)
enters the catalytic center in association with an
Mg
2+ ion, termed metal B [Mg(B)]. When bound to
RNAP II, Mg(B) is coordinated by the b and g phos-
phates of the NTP, Rpb1 residues D481 and D483 and
Rpb2 residue D837. Rpb2 residue D837 is highly con-
served across species. Notably, its neighboring res-
idue, E836 (E791 in human RNAP II), is also highly
conserved. To probe the role of E791 in transcription,
we have affinity purified and characterized a human
RNAP II mutant in which this residue was substituted
for alanine. Our results indicate that the transcription
activity of the Rpb2 E791A mutant is impaired at low
NTP concentrations both in vitro and in vivo. They
also revealed that both its NTP polymerization and
transcript cleavage activities are decreased at low
Mg concentrations. Because Rpb2 residue E791
appears to be located too far from the NTP–Mg(B)
complex to make direct contact at either the entry
(E) or addition (A) site, we propose alternative mech-
anisms by which this highly conserved residue parti-
cipatesinloadingNTP–Mg(B)intheactivesiteduring
transcription.
INTRODUCTION
RNA polymerase (RNAP) II, the enzyme that synthesizes
mRNA in mammals, is composed of 12 subunits, termed
Rpb1–Rpb12 (1,2). Crystal structures of yeast RNAP II
(3–7) have conﬁrmed that the two largest subunits, Rpb1
andRpb2,formtheenzyme’scatalyticcenter. These structures
also revealed the presence of a cleft at the surface of the
enzyme, which buries this active center. The cleft is formed,
on one side, by a mobile ‘clamp’ which is connected to the
protein by a series of ﬁve ‘switch’ regions. In the elongation
complex, the DNA enters the cleft through a pair of ‘jaws’ and
the DNA helixisopened beforethe active center. Thetemplate
strand binds to switches 1 and 2 and the ‘bridge’ helix. Beyond
the bridge, the template strand and the nascent RNA form a
9 bp duplex. Beneath the active site and in line with the bridge
is found a ‘pore’ or secondary channel; the space formed by
the cleft at the surface of the protein being the main channel.
The secondary channel widens towards the bottom of RNAP
II, forming an inverted ‘funnel’. In the past, both channels
have been proposed as privileged routes for NTP entry, and
pyrophosphate exit (3,4,8).
DNA and RNAPs catalyze the nucleophilic attack of the 30
hydroxyl of a ﬁrst nucleotide on the a-phosphate of a second
incoming NTP, leading to phosphodiester bond formation and
the release of a pyrophosphate molecule. Based on crystal
structures of T7 DNA polymerase (9) and Bacillus stearother-
mophilus DNA polymerase (10), a two metal ion mechanism
has been proposed (11,12). Through this mechanism, a ﬁrst
Mg
2+ ion [metal A or Mg(A)] lowers the afﬁnity of the 30
oxygen for the hydrogen thereby facilitating the O
  attack on
the 50 a-phosphate. The second Mg
2+ ion [metal B or Mg(B)]
facilitates the release of the pyrophosphate. High-resolution
crystal structures of yeast RNAP II revealed the position of the
two Mg
2+ ions in the catalytic site of the enzyme (3,4,13). In
the yeast RNAP II structure, Mg(A) is coordinated by three
aspartate residues of Rpb1, D481, D483 and D485, contained
within the strictly conserved motif NADFDGD (3,4,13).
Mg(B) was recently localized near residue D481 and D483
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(13). However, previous studies have suggested that the highly
conserved residue E836 is also implicated in the coordination
of Mg(B) in the active site (3,4). A number of studies have also
proposed that Mg(B) would necessitate the presence of the
incoming NTP for its complete coordination required for the
polymerization process (3,4,8,13). However, biochemical data
in support of the role of E836, D837 and NTP as Mg(B)
coordinating residues is currently lacking.
In addition to their polymerization activity, DNA-
dependent RNAPs can also catalyze the 30 endonucleolytic
cleavage of transcripts to stimulate elongation (14,15). First
discovered in Escherichia coli (16,17), this cleavage activity
takes place when RNAP has backtracked at pause and arrest
sites (18,19). Weakly associated DNA–RNA hybrids can
induce backtracking of the enzyme to a more stable register
(20). To resume elongation from this more stable position,
RNAP needs to cleave the 30 end of the transcript that now
extrudes from the catalytic site through the pore. This intrinsic
nuclease activity is stimulated at basic pH, strongly suggesting
a hydrolytic mechanism rather than pyrophosphorolysis (21).
The 30 cleavage activity is also enhanced by speciﬁc factors,
GreA and GreB in bacteria (22,23) and TFIIS in eukaryotes
(18,19). TFIIS was ﬁrst identiﬁed as an elongation factor that
helps RNAP II to elongate through arrest sites in vitro (24,25).
TFIIS greatly stimulates the intrinsic nuclease activity of
RNAP II (26–28). The crystal structure of TFIIS in a complex
with RNAP II (29) provided insight into the mechanism by
which this factor enhances transcript cleavage. Speciﬁcally, it
revealed that two conserved acidic residues in TFIIS essential
foritsactivity(30),arelocatedinthevicinityofthepolymerase
Mg(B) and could participate in its coordination. Therefore,
it was suggested that a two metal ion mechanism is involved
in the 30 endonucleolytic activity of RNAP II. A two metal ion
mechanism is consistent with the requirement for divalent
cations for the cleavage activity (27). In addition, recent stud-
ies on GreB, the prokaryotic homolog of TFIIS, have also
provided evidence for a two metal ion mechanism for the
30 transcript cleavage activity of bacterial RNAP (31,32).
In order to investigate the role of the highly conserved
residues E791 and D792 of Rpb2 (equivalent to E836 and
D837 in yeast RNAP II), we have studied mutant RNAP II
having alanine substitutions in these residues. We found that
the D792A substitution in Rpb2 impairs the assembly of
RNAP II, thereby preventing the study of its effect during
transcription. In contrast, the E791A substitution does not
affect assembly of the enzyme but rather makes its polymer-
ization activity more sensitive to low NTP concentrations and
both its polymerization and cleavage activities more sensitive
to low Mg
2+ concentrations. Accordingly, we found that
the equivalent substitutionin yeast Rpb2, E836A, confers sensit-
ivity to low nucleotide concentrations in vivo, while D837A is
lethal either alone or in combination with E836A. Our results
demonstrate for the ﬁrst time that amino acid E791 (E836 in
yeast) participates in the binding of Mg(B) in the active site
and is required both for the polymerization and cleavage reac-
tions. They also support the hypothesis that this second Mg
2+
ion enters the catalytic center with the incoming NTP. We
propose, for the polymerization reaction, that Rpb2 E791
interacts with the NTP–Mg(B) complex and participates in
its loading to the active site prior to catalysis.
MATERIALS AND METHODS
Protein factors
Recombinant yeast TBP (33), human TFIIB (34), RAP74 and
RAP30 (35), TFIIE56/a and TFIIE34/b (36–38), TFIIH
(39,40), calf thymus RNAP II (41) and GST-TFIIS (42)
were puriﬁed as previously described.
Tandem affinity purification of wild-type and
mutant RNAP II
TAP-tagged wild-type and mutant RNAP II subunits were
expressed in human EcR-293 cells and puriﬁed as previously
described (43,44).
Gel mobility shift assay
Gel mobility shift assays were performed as previously
described (45) with the following modiﬁcations. Complexes
were assembled using highly puriﬁed TBP (40 ng), TFIIB
(120 ng), RAP30 (200 ng), RAP74 (400 ng), TFIIE34 (80 ng),
TFIIE56 (110 ng) and wild-type or mutant RNAP II (450 ng).
Run-off transcription assay
Transcription reactions were performed as described previ-
ously (42). TBP (30 ng), TFIIB (30 ng), RAP30 (30 ng),
RAP74 (65 ng), TFIIE34 (40 ng), TFIIE56 (60 ng), TFIIH
(4 ng) and wild-type or mutant RNAP II (165 ng) were incub-
ated with 500 ng of linearized DNA template containing the
adenovirus major late (AdML) promoter from nt  50 to +10
fusedtoaG-lesscassette. Reactions were performedatvarious
concentrations of NTP speciﬁed in the ﬁgure legends. Under
these conditions a 391 nt run-off transcript is produced.
Transcription assay on immobilized template
A biotinylated template containing the AdML promoter from
nt  50 to +10 fused to a G-less cassette and modiﬁed to
contain a G at position +24 was immobilized on Dynabeads
(Dynal, Oslo, Norway) according to the manufacturers’
recommendations. The biotinylated template (225 ng) was
pre-incubated with TBP (15 ng), TFIIB (15 ng), RAP30
(15 ng), RAP74 (30 ng), TFIIE34 (20 ng), TFIIE56 (30 ng),
TFIIH (2 ng) and RNAP II (83 ng) for 30 min at 30 Ci n
transcription buffer (12 mM HEPES pH 7.9, 50 mM KCl,
0.1 mM EDTA, 0.1 mM EGTA, 10% glycerol, 1 mM DTT).
Mix 1 was added (100 mM ATP, 100 mM CTP and 5 mCi
of 0.08 mM[ a-
32P]UTP, 3 mM EGTA, 12.5 mM MgCl2,
1U / ml RNase inhibitor) and transcription was allowed to
proceed for 30 min at 30 C. Beads were then washed sequen-
tially with 10 vol of 2· transcription buffer containing 0.3%
sarkosyl and 1 mg/ml BSA, 5 vol of 2· transcription buffer
containing 1 mg/ml BSA and 5 vol of 1· transcription buffer
containing 1 mg/ml BSA. Beads were resuspended in 1· tran-
scription buffer and incubated for 30 min at 30 C with Mix 2
(variable concentrations of ATP, CTP and UTP, 3 mM EGTA,
12.5mMMgCl2and1U/mlRNaseinhibitor;seeﬁgurelegends).
Transcription was stopped by adding 200 ml of stop solution
(0.1 M sodium acetate, 0.5% SDS, 2 mM EDTA, 100 mg/ml
tRNA). After phenol/chloroform extraction and ethanol
precipitation, transcripts were analyzed on an 18% polyacryl-
amide, 9% urea denaturating gel.
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The Saccharomyces cerevisiae strain yBC-1, which condition-
ally expresses Rpb2 under the control of the Gal1 promoter,
was constructed in two steps. First, strain W303-1A (MATa
can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1) was
transformed with the plasmid pGAL-RPB2 (URA3). Second,
the chromosomal RPB2 allele of this merodiploid strain was
disrupted with LEU2. The resulting strain, yBC-1, is depend-
ent on galactose for growth. To test the phenotype associated
with the substitutions E836A, D837A and the double substi-
tution E836A D837A, plasmids encoding these different rpb2
alleles (cloned into pFL39 [TRP1, CEN, ARS]), or wild-type
RPB2 as a control, were introduced into yBC-1 and transform-
ants selected on galactose-medium lacking tryptophan. These
transformants were then streaked onto three different media,
either synthetic galactose-medium or glucose-medium lacking
or containing 6-AU (50 mg/ml) and grown at 30 C for 5 days.
In a separate experiment, the different mutant rpb2 alleles
were also introduced into the wild-type yeast strain W303-1A
in order to test if they confer a dominant-lethal phenotype.
Transformants were selected on synthetic glucose-medium
lacking tryptophan. Yeast transformations were performed
as previously described (46). Details on the construction of
these plasmids will be provided upon request.
Cleavage assay
RNAP II complexes stalled at nucleotide +24 were formed as
described above with Mix 2 containing 100 mM of non-
radioactive ATP, CTP and UTP, 3 mM EGTA, 12.5 mM
MgCl2 and 1 U/ml RNase inhibitor. Beads were washed
three times with 5 vol of 1· transcription buffer containing
1 mg/ml BSA. Beads were resuspended either in 20 mlo f
cleavage buffer pH 9.5 (70 mM CAPS–KOH, pH 9.5, 100 mM
KCl, 5mM MgCl2, 5% glycerol and 1 mM DTT) and
incubated for 1 h at 30 C, or in 20 ml of TFIIS containing
buffer pH 8 (70 mM Tris, pH 8, 100 mM KCl, 5 mM MgCl2,
5% glycerol, 1 mM DTT and 0.42 ng/ml TFIIS) and incubated
for 5 min at 30 C. In the experiments shown in Figure 3D,
various concentrations of MgCl2 were used in the cleavage
bufferpH9.5asindicated. Cleavage reactionswere stoppedby
the addition of 200 ml of stop solution and transcripts were
processed as described above.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed
as previously described (47,48) with the modiﬁcations imple-
mented by Jeronimo et al. (44). Cell lines expressing the
following RNAP II mutants were analyzed: wild-type
RNAP II, MB E791A/D792A, MB E791A and MB D792A.
A mock-transfected cell line was used as a negative control.
Quantitative PCR (Q-PCR) experiments were performed as
previously described (49). Primer pairs were designed for
both the promoter and transcribed regions of GNB2L1
( 200 to +55 and +998 to +1165, respectively), FTL ( 157
to +33 and +955 to +1176, respectively) and ENO1 ( 90 to
+91 and +1143 to +1292, respectively) genes. The position
of the promoter and transcribed regions was selected based on
the major transcription start site listed in the DataBase of
Transcription Start Site (DBTSS, April 2003 version, http://
dbtss.hgc.jp/samp_home.html) and the Mammalian Gene
Collection (MGC, March 2003 version, http://mgc.nci.nih.
gov/). Oligonucleotide sequences will be made available
upon request. Relative immunoprecipitation efﬁciency was
calculated bydividing the amount ofDNAfragments spanning
the promoter or coding region of the speciﬁed genes by the
amount of DNA fragments from a conserved gene-less region
located in the 13q21.33 band (50) in the immunoprecipitated
sample. Data points originate from two independent sets of
duplicate Q-PCR using chromatin obtained from three inde-
pendent immunoprecipitations, giving a total of 12 data points
for each immunoprecipitation.
Molecular modeling
Modeling was performed using the crystallographic structure
of elongating yeast RNAP II (4,13) and the program Swiss
PDB viewer.
RESULTS
RNAP II mutant MB E791A is sensitive to low NTP
concentrations
The Rpb2 mutants MB E791A, MB D792A and MB E791A/
D792A were designed to experimentally assess whether these
highly conserved residues are involved in the coordination of
Mg(B) in the active center, as predicted by early crystallo-
graphic data (3,4). Only MB E791A assembled correctly in the
cell extract (Figure 1A) and was able to form a preinitiation
complex with the general initiation factors on promoter DNA
in vitro (Figure 1B). Both MB D792A and MB E791A/D792A
lacked some of the small RNAP II subunits. As expected from
their assembly defect, both MB D792A and MB E791A/
D792A were also defective in run-off transcription reactions
(data not shown). In contrast, the correctly assembled mutant
MB E791A was able to synthesize an accurately initiated
391 nt run-off transcript, albeit less efﬁciently than the wild-
type enzyme (Figure 2A).
Previous reports have shown that the substitution equivalent
to E791A in E.coli (51) and in the archae Methanococcus
jannaschii (52) impaired the ability of these enzymes to tran-
scribe at low NTP concentrations. As shown in Figure 2A, the
human mutant MB E791A is also sensitive to low NTP
concentrations in vitro. Increasing the concentration of non-
radioactive UTP in the assay partially alleviated the failure of
MB E791A to produce run-off transcripts, but had no effect on
the wild-type enzyme. Because the same amount of radioact-
ive UTP (0.08 mM, 0.25 mCi) was used in all of the assays,
increasing the concentration of unlabeled UTP from 2.5 mM
UTP to 10 mM resulted in less incorporation of the labeled
NTP in the 391 nt transcript synthesized by the wild-type
enzyme, as indicated by the lower intensity of that band.
Further increasing the concentration of non-radioactive UTP
>40 mM led to a decrease in signal for both the wild-type and
the mutant enzyme.
To conﬁrm the sensitivity of MB E791A to NTP concen-
tration, we immobilized the biotinylated template on strep-
tavidin coated beads. The template used contained the
AdMLpromoterthatdirectedthe synthesisofa 24nttranscript
in the absence of GTP as it contains a G residue at position +24
(see Figure 2B for a schematic representation). Wild-type
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the immobilized template. Transcription was allowed to pro-
ceed for30min inthe presence ofa mixof NTP(Mix 1).Mix 1
contained 100 mM of ATP and CTP and 5 mCi of 0.08 mM
[a-
32P]UTP and allowed the synthesis of transcripts of various
lengths (Figure 2B, lanes 1 and 6). Under these conditions, the
wild-type enzyme was able to predominantlyproduce the 24 nt
transcript. In contrast, the majority of the MB E791A enzyme
was stalled at around +10, indicating that the mutant enzyme is
impaired in its ability to transcribe at limiting NTP concen-
trations. Increasing the concentration of non-radioactive NTP
in Mix 2 stimulated production of the 24 nt transcript by the
mutant polymerase (compare lanes 7–10 with lanes 2–5). At
0.64 mM of NTP, the mutant was as active as the wild type
enzyme.
We then wished to determine the phenotypes associated
with the Rpb2 substitutions E836A (E791A), D837A
(D792A) and the double substitutions E836A D837A
(E791A D792A), in S.cerevisiae. To do so, the mutant rpb2
alleles as well as the wild-type allele, all expressed from the
endogenous RPB2 promoter and cloned into a centromeric
plasmid (TRP, CEN, ARS), were introduced into yeast strain
yBC-1. In this strain, the chromosomal RPB2 allele has been
disrupted (Rpb2::LEU2) and is complemented by a plasmid
expressing a galactose-inducible RPB2 gene (pGal-Rpb2).
On galactose-containing medium, both the wild-type Rpb2
encoded by the pGAL-Rpb2 allele and the mutant or wild-
type Rpb2 under the control of the endogenous RPB2
promoter, are expressed. However, on glucose-containing
medium transcription from the pGal promoter is repressed
and only the wild-type or mutant Rpb2 allele transcribed
from the endogenous promoter is expressed. Figure 2C
shows that transformation of yBC-1 with the RPB2 D837A
expressing vector has a dominant-negative effect on cellular
growth and/or viability. This dominant effect, which was also
observed in the wild-type strain W303-1A (data not shown),
suggests that the Rpb2 D837A subunit interferes with the
function of wild-type RNAP II. In contrast, expression of
the mutant Rpb2 E836A and E836A D837A had no dominant
effect on the growth of yBC-1 on galactose (Figure 2C).
Viable yBC-1 transformants expressing these mutant proteins
were then streaked on glucose-containing medium (Figure 2D)
to repress expression of the pGal-Rpb2 allele and reveal the
recessive phenotypes associated with these mutant subunits.
While the Rpb2 E836A subunit could support yeast growth on
glucose medium, the double mutant Rpb2 E836A D837A was
found to be lethal. Similar results were obtained in a strain
lacking TFIIS (data not shown).
We then tested if Rpb2 E836A could support cell growth
in the presence of 6-azauracil (6-AU), an inhibitor of
IMP-dehydrogenase, which leads to a depletion of the intra-
cellular pool of GTP and UTP (53). Most yeast mutants with
Figure 1. Purification of wild-type and metal B mutant RNAP II and characterization of their ability to form a pre-initiation complex. (A) The TAP purification
procedurewasusedtoisolatewild-type(wt)andmutant(MBE791A,D792A;MBE791A;MBD792A)RNAPII.ThepurifiedRNAPIIwerevisualizedonaSDSgel
stainedwithsilver.ThepositionofmolecularweightmakersandRNAPIIsubunitsareindicated.(B)AnEMSAwasperformedusingeitherwild-typeRNAPIIorMB
E791AinthepresenceofTBP,TFIIB,TFIIFandTFIIE.AcontrolreactionassembledintheabsenceofTBPisincludedineachcase.ThepositionoftheTBP-IIB-IIF-
IIE–RNAP II-promoter complex is indicated.
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on 6-AU containing medium (54). This was also found to be
the case for cells expressing Rpb2 E836A, which showed
severely reduced growth on glucose-medium supplemented
with 50 mg/ml 6-AU, as compared with wild-type cells
(Figure 2C). We found that the 6-AU sensitivity imposed
by the E836A substitution in Rpb2 was more pronounced
than that associated with the previously reported rpo21-18
or rpo21–24 mutations in Rpb1 (data not shown), which
affect the binding of TFIIS to RNAP II (55). These results
suggest that the yeast E836A RNAP II is sensitive to low
nucleotide concentrations in vivo, consistent with the in
vitro transcription results obtained for the human RNAP II
counterpart (E791A).
Figure 2. MutantMBE791Ais sensitiveto NTP concentrations duringpolymerization.(A) Invitrotranscriptionreactionswerereconstituted witheitherwild-type
RNAP II or MB E791A in the presence of TBP, TFIIB, TFIIF, TFIIE and TFIIH. The linearized AdML template directs the synthesis of a 391 nt transcript. The
reaction contained 750 mM ATP and CTP, 2.5 mCi of 0.04 mM[ a-
32P]UTP and increasing amounts of non-radioactive UTP, as indicated in the figure. (B) In vitro
transcription reactions on immobilized template. A scheme of the transcription procedure is presented. Transcriptional complexes were assembled with wild-type
RNAPIIorMBE791mutantinthepresenceofTBP,TFIIB,TFIIF,TFIIEandTFIIHontheimmobilizedtemplate.TheAdMLtemplatedirectsthesynthesisofa24nt
transcriptintheabsenceofGTP.(C)TheS.cerevisiaestrainyBC-1(RPB2::LEU2,pGAL-RPB2)wastransformedwitheitherthewild-typeormutantE836A,D837A
or E836A D837A RPB2 allele cloned into a centromeric plasmid (pFL39; TRP1, CEN, ARS) and transformants selected on synthetic galactose-medium lacking
tryptophan at 30 C. The pictures show the growth of Trp+ transformants expressing the indicated RPB2 allele 3 days post-transformation. (D) The yBC-1
transformants from (C) were streaked on synthetic galactose medium, as well as on glucose medium containing or lacking 6-AU (50 mg/ml), and grown at
30 C for 5 days.
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MgCl2 concentrations both during NTP polymerization
and transcript cleavage
To test the hypothesis that E836/E791 is involved in the
binding of the second Mg
2+ ion, we looked at the ability of
MB E791A to transcribe at different MgCl2 concentrations.
Figure 3Aand B show that MB E791Aismore sensitive tolow
MgCl2 concentrations than wild type when assayed for the
production of the 24 nt transcript from immobilized templates.
These results strongly suggest that Rpb2 amino acid E791 is
involved in the binding of Mg(B) during NTP polymerization.
Since a two metal ion mechanism was also proposed for the
cleavage activity of RNAPs (30–32), we tested the ability of
the mutant MB E791A to cleave the 30 end of a transcript. In
the experiments shown in Figure 3C and D, wild-type and
mutant RNAP II were stalled at G + 24 using our transcription
assay on immobilized templates, with a Mix 2 containing
100 mM ATP, CTP and UTP. Complexes were washed and
incubated at pH 9.5 in the absence of NTP for 1 h. It has been
shown that in a stalled complex, RNAP II is able to cleave the
30 end of a transcript ata basic pH in the absence of TFIIS (21).
At pH 8, intrinsic cleavage is almost completely abolished, but
increasing the pH to 9.5 stimulates this RNAP II activity. The
cleavage activity of RNAP II can also be greatly stimulated
by the addition of TFIIS. Figure 3C shows that MB E791A is
able tocleave the 30 end ofa transcript asefﬁcientlyas the wild
type. At pH 9.5, the wild-type and the mutant cleave the RNA
at two major sites, one at +22 and the other at +18. The
addition of TFIIS stimulates both the wild type and the mutant
to cleave, favoring the ﬁrst (+22) site.
Previous studies using an E.coli mutant RNAP (E813A/
D814A) analogous to our double mutant MB E791A/D792A
have suggested that these two residues are not involved in the
coordination of Mg(B) in the catalytic site (56). Speciﬁcally,
using a cleavage assay similar to the one used in Figure 3C,
Goldbarb and colleagues have shown that the ability of the
mutant enzyme to cleave the 30 end of a transcript was equival-
ent to that of the wild-type enzyme atall MgCl2concentrations
tested. We therefore determined the effect of decreasing the
MgCl2 concentration on the cleavage activity of MB E791A
atpH9.5(Figure3D).Wemeasuredthedisappearanceofthe24
nt band for the wild type and the mutant at different MgCl2
concentrations (x-axis). The y-axis represents the ratio of the
intensityofthecleavedbandtotheuncleavedband.Incontrastto
Sosunov et al. (56) the graph shows that at low MgCl2 concen-
trations, MB E791A is less active than wild type. At higher
MgCl2 concentrations (5 mM), the mutant is as efﬁcient as
the wild type. Together, these results show that Rpb2 amino
acidE791isinvolvedinthebindingofMg
2+intheactivesiteof
RNAP II for both the polymerization and cleavage reactions.
Figure 3. Mutant MB E791A is sensitive to MgCl2 concentrations during both NTP polymerization and transcript cleavage. (A) In vitro transcription reactions on
immobilizedtemplateatdifferentMgCl2concentrationsinMix1.Reactionswerestopped30minafteradditionofMix1.(B)Theintensityofthe24nttranscriptband
obtainedateachMgCl2concentrationwasquantifiedusingaphosphorimagerandnormalizedtotheintensityofthebandobtainedat9.33mMMgCl2.Theserelative
values are reported on the y-axis of the graph and are the mean of three independent experiments. (C) Cleavage reactionswere performed as described in Figure 4B
exceptthatMix2contained100mMATP,100mMCTPand100mMUTP.After30minincubationwithMix2,complexeswerewashedandincubatedfor1hatpH9.5
or for5minat pH8 inthe presenceof8.2ng ofTFIIS.(D) The intensityofthe 24nt transcriptbandwasquantifiedusinga phosphorimager fromcleavagereactions
performedfor1hatpH9.5inabuffercontainingtheindicatedconcentrationsofMgCl2.Theintensityofeachbandwasdividedbytheintensityoftheuncleavedband
(reactionstoppedafter30minofincubationwithMix2)andreportedonthey-axisofthegraph.Theratioscalculatedarethemeanofthreeindependentexperiments.
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MB E791A RNAP II at limiting NTP concentrations
in vitro
In yeast, the TFIIS gene (DST1) is not essential for viability
(57,58). However, knocking out the gene confers sensitivity to
6-AU (57,58). In vitro experiments have shown that reducing
the concentration of NTPs causes RNAP II to pause and over-
all elongate less efﬁciently (26,27,59). Since MB E791A is
sensitive to low nucleotide concentrations, we decided to test
the effect of TFIIS on transcription by this mutant in vitro.
Figure 4A shows that at 10 mM UTP, TFIIS stimulates syn-
thesis of the 391 nt transcript by MB E791A but has no effect
on transcription by the wild-type enzyme. Reducing UTP con-
centrations from 2.5 to 0.625 mM causes a decrease in the
synthesis of the run-off transcript by the wild-type enzyme
and causes the enzyme to arrest at different sites (Figure 4B).
At these limiting concentrations of NTP, TFIIS now stimulates
transcription by the wild-type RNAP II. These in vitro results
conﬁrm that TFIIS helps RNAP II to transcribe at low NTP
concentrations, as suggested by previous in vivo experiments
(57,58). We hypothesize that TFIIS helps RNAP II to resume
arrest at low NTP concentrations by stimulating its 30 tran-
script cleavage activity, possibly by stabilizing the binding of
Mg(B) in the active site.
Metal B mutant E791A is defective for transcription
in vivo
In order to determine the transcriptional defects of the human
MB E791A mutant in vivo, ChIP experiments were performed
usingIgG beads toprecipitate the different TAP-tagged RNAP
II bound to chromatin (Figure 5). Q-PCR was used to deter-
mine the enrichment of wild-type and mutant RNAP II on the
promoter and coding region of 3 actively transcribed genes
relativetoanuntranscribedregion.Thethreetranscribedgenes
used in these studies were: the ferritin light polypeptide gene
(FTL), the guanine nucleotide binding protein beta polypep-
tide 2-like 1 gene (GNB2L1) and the enolase 1 (alpha) gene
(ENO1).
As we previously described (44), wild-type TAP-tagged
RNAP II was found at the promoter and in the transcribed
region of the three genes tested, in substantially greater
amounts than in the negative control (mock-transfected cell
line). Consistent with the observation that MB E791A is able
to form a pre-initiation complex in vitro, this mutant was
present at the promoter of FTL, GNB2L1 and ENO1 genes
in vivo. Our results indicate that MB E791A is also located in
the coding region of all three genes, albeit at a lower level than
wild type. For the FTL and GNB2L1 genes, the MB E791A
mutation had a greater effect on the density of RNAP II in the
coding region than at the promoter. For the ENO1 gene, the
mutant is similarly affected in both regions. Taken together,
our ChIP results indicate that the E791A mutation has a more
profound impact on transcript elongation than promoter
recruitment in vivo.
We propose that a similar situation takesplace in yeast cells.
In the yeast strain carrying the E836A mutation, the RNAP II
mutant is probably altered in its elongation efﬁciency on
some genes but to an extent that does not affect growth
under normal conditions. The addition of the drug 6-AU
has a dramatic effect on growth of the mutant since it further
reduces the altered enzyme’s capacity to elongate by lowering
the concentration of nucleotides in the cell (Figure 2C). The
ﬁnding that mutant MB E791A is less efﬁciently recruited to
promoters and less present in the transcribed regions in vivo
cannot be explained solely by the in vitro defects presented in
this article. We speculate that, in vivo, other factors that regu-
late transcription interact with the mutated polymerase and
affect its ability to associate with promoters and to transcribe.
DISCUSSION
In this study, we have puriﬁed and characterized a human
RNAP II mutant in which the highly conserved residue
E791 of Rpb2 has been substituted for an alanine. Our results
indicate that the Rpb2 E791A substitution in the human
enzyme alters both its polymerization activity at low NTP
concentrations (in vitro, see Figure 2A and B; in vivo, see
Figure 2C) or at low Mg concentrations (Figure 3A and B)
and its transcript cleavage activity at low Mg concentrations
(Figure 3C and D). Although previous reports have shown that
the substitution equivalent to E791A in the RNAP of E.coli
(51) and the archae M.jannaschii (52) impaired the ability of
these enzymes to transcribe at low NTP concentrations, our
results provide, what is to our knowledge, the ﬁrst biochemical
evidence that the E791A substitution reduces transcription at
low Mg concentrations. Indeed, previous studies using an
E.coli mutant RNAP(E813A/D814A) analogous to our double
mutant MB E791A/D792A have suggested that these two
Figure 4. TFIIS stimulates transcription of both wild-type RNAP II and mutant MB E791A at low NTP concentrations. (A) In vitro transcription reactions were
reconstituted using wild-type or mutant RNAP II in the presence of TBP, TFIIB, TFIIF, TFIIE, TFIIH and various amounts of TFIIS where indicated. The reaction
contained 750 mM ATP and CTP, 10 mM UTP and 2.5 mCi of 0.04 mM[ a-
32P]UTP. (B) Reactions were performed as in (A) for the wild-type RNAP II with the
exception that reactions contained various amounts of non-radioactive UTP and 4.1 ng of TFIIS, where indicated.
Nucleic Acids Research, 2005, Vol. 33, No. 8 2635residues are not involved in the coordination of Mg(B) in the
catalytic site (56). Speciﬁcally, using a cleavage assay similar
to the one used in Figure 3C, Goldbarb and colleagues have
shown that this mutant enzyme cleaves the 30 end of a tran-
script as efﬁciently as the wild-type enzyme at all MgCl2
concentrations tested. The discrepancy between our results
and those of Goldfarb and colleagues might accounted for
by the fact that MgCl2 concentrations <5 mM were not tested
by Sosunov et al. (56).
At high NTP concentrations, TFIIS was found to stimulate
elongation of the Rpb2 E791A mutant, but not that of
wild-type RNAP II (Figure 4). Stimulation of the wild-type
enzyme by TFIIS was only observed when the NTP concen-
tration was made limiting. These data support previous in vivo
results showing that TFIIS helps RNAP II to transcribe at low
NTP concentrations (57,58), presumably by increasing NTP–
Mg(B) binding in the enzyme’s active site. Our ﬁnding that
TFIIS is able to stimulate transcript elongation at high NTP
concentrations by a RNAP II having the Rpb2 E791A substi-
tution supports a role for this residue in NTP–Mg(B) binding.
A lower density of the mutated RNAP II along transcribed
genes, as determined by ChIP experiments in vivo (Figure 5),
is also consistent with the roleof E791 intranscript elongation.
Recently, Kornberg and co-workers (13) have published the
crystal structure of yeast RNAP II bound to a DNA–RNA
duplex and a nucleotide positioned at the i + 1 site, poised
for bond formation. In this structure, Mg(B) was found to be
located in proximity to Rpb1 residues D481 and D483 and
Rpb2 D837. On this basis, the authors proposed that these
amino acids are implicated in Mg(B) coordination at the active
site. At this step of the polymerization process, Rpb2 E836 is
located too far from Mg(B) to interact with it. The structure of
a RNAP II with a mismatched nucleotide revealed the exist-
ence of a second binding site for the incoming NTP, called the
‘entry’ or E site. It was suggested that the NTP–Mg(B) com-
plex enters the active site through the pore and ﬁrst binds to the
E site in an inverted orientation, followed by a rotation and
subsequent binding to the so-called ‘addition’ or A site.
To account for our results showing that the mutant E791A is
sensitive to NTP and MgCl2 concentrations during the poly-
merization reaction, we propose thatRpb2E836/791 isimplic-
ated in loading the NTP–Mg(B) into the E site. We can
envisage two distinct mechanisms by which this could
occur. First, it is possible that the Rpb2 E791 side chain is
essential for specifying the proper topology of the E site. In
this case, substituting E791 for alanine could conceivably
modify the conﬁguration of the E site, for example, by affect-
ing the precise positioning of residue D792, such as to reduce
its binding afﬁnity for the incoming NTP–Mg(B). Alternat-
ively, it is possible that Rpb2 E791 deﬁnes a third and distinct
NTP–Mg(B) binding site within the active center, which we
willrefertoasthe‘pre-loading’(P)site.Figure6Adepictshow
an incoming NTP–Mg(B) entering the active site through the
pore would ﬁrst interact transiently with the P site (panel 1),
before being loaded in the E site at a position where metal B
can interact with Rpb2 D837, Rpb1 D481 and D483 and the
NTP b and g phosphates, as described (13) (panel 2). The
nucleotide is next ﬂipped and positioned at the A site for
catalysis (panel 3). Consistent with the existence of a P site,
we note that E836/E791 is the acidic residue within the vicin-
ity of the active site that is the most accessible to an incoming
NTP–Mg(B) entering from the pore.
In a recent series of papers, Burton and colleagues have
proposed that the incoming NTPs access the active center
through the main channel (8,60,61). Furthermore, these
authors have proposed an NTP-driven translocation model
in which the incoming NTP pairs with the DNA base at the
i + 2 site. According to this model, this pairing is necessary to
induce translocation of the NTP at the i + 1 site (A site) for
catalysis and allows substrate selection prior to arrival into the
catalytic site. Our data is also consistent with the idea that the
NTPs access the catalytic center through the main channel.
Figure 5. Association of wild-type and mutated RNAP II with chromatin
in vivo. Fold enrichment over the control region of both the promoter and
the transcribed region of FTL, GNB2L1 and ENO1 genes following immuno-
precipitation of chromatin fragments was determined using Q-PCR. Enrich-
ment was normalized to a conserved gene-less region located in the 13q21.33
band (see Materialsand Methods). Data pointsoriginatefrom two independent
sets of duplicate Q-PCR using chromatin obtained from three independent
immunoprecipitations, giving a total of 12 data points for each immunopreci-
pitation. The negative control is a mock transfected cell line.
2636 Nucleic Acids Research, 2005, Vol. 33, No. 8This would imply, as depicted in Figure 6B, that Mg(B) is
implicated in an interaction with E836 (panel 2) during trans-
location of the NTP–Mg(B) from the i + 2 site (panel 1) to the
A site (panel 3). The interaction of E836 with NTP–Mg(B)
would play a crucial role in loading the NTP or retaining it in
the active siteforcatalysis. Ifthismodeliscorrect,the position
of the E site would be more consistent with it being a site for
expulsion and subsequent exit of a mismatched nucleotide.
Figure 6. Proposed models for the NTP polymerization reaction. (A) The NTP–Mg(B) accessing the active center from the pore first binds to a ‘Pre-entry’ (P) site
whereitcancontactRpb2residueE836/E791andotherresiduesthatremainedtobeidentified.FromthePsite,theNTP–Mg(B)movestotheEsitebeforerotatingto
access the A site where it is paired with the template DNA. (B) The incoming NTP–Mg(B) can alternatively enter the catalytic center through the enzyme’s main
channel and associate with E836/E791 in the P site. The subsequent steps are as in (A). The exact location of the P site is speculative. See text for details. Incoming
NTP: pink; Rpb1 D481, D483, D485, bridge helix: green; Rpb2 E836: yellow; Rpb2 D837: orange; RNA: magenta; DNA: blue; and metal A and B: red.
Nucleic Acids Research, 2005, Vol. 33, No. 8 2637The mutant MB E791A is also sensitive to MgCl2 concen-
trationinthecleavage reaction, suggestingthatE791isimplic-
ated in binding Mg(B) for this activity of the polymerase.
High-resolution structures of RNAP II engaged in transcript
cleavage will be required to determine the molecular basis
of the interaction between E836 and Mg(B) during the rescue
of backtracked transcripts.
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